The pancreas secretes compounds that guide processing and hormones that help control the digestion of sugars. This kind of malignant growth is regularly identified late, spreads quickly and has a poor anticipation. There are no side effects in the beginning times. Later stages are related with side effects, yet these can be vague, for example, absence of craving and weight reduction.
From US$ 2,011.2 million in 2017, the worldwide market for pancreatic cancer therapy is anticipated to reach US$ 4,056.4 million in 2025. It is projected that the industry will expand with an 8.1% CAGR from 2018-2025.
• Adenosquamous carcinomas
• Squamous cell carcinomas
• Giant cell carcinomas
• Insulinomas (Insulin)
• Glucagonomas (Glucagon)
• Gastrinomas (Gastrin)
• Somatostatinomas (Somatostatin)
• VIPomas (Vasoactive Intestinal Peptide)
ALSO READ Oncology Pancreatic Cancer Breast Cancer Oral and Oropharyngeal Cancer Eye Cancer Uterine Cancer Lung Cancer Skin Cancer Kidney Cancer Bladder Cancer Prostate Cancer Colorectal Cancer Anal Cancer Cervical Cancer Bone Cancer Liver Cancer Stomach Cancer Blood Cancer Brain Cancer Gastrointestinal Cancer Ovarian and Testicular Cancer Cardio-Oncology Biochemistry of Cancer Cancer Biomarkers Cancer and HIV Cancer Research and Cancer Vaccines Cancer Genetics Cancer Trends and Opportunities Nanotechnology Nanomedicine in Cancer Treatment Radiology and Imaging in Cancer Artificial Intelligence AI and its Scope in Cancer Therapy Treatment of Cancer Nutrition and Oncology
Immuno Therapy Conferences Cancer Therapy Conferences 2020 USA Cancer Cell Conferences Cancer Therapy Conferences 2020 Nuclear Medicine Conferences Cancer Research Conferences Breast Cancer Conferences Immuno-oncology Conferences Surgical Oncology Conferences Oncology Conferences Oncology Conferences 2020 Australia Geriatric Oncology Conferences Cancer Therapy Conferences 2020 Australia Oncology Conferences 2020 Europe Tissue Size Conferences